Linguistic validation of the lupusqol for the assessment of quality of life in iranian patients with systemic lupus erythematosus

International Journal of Rheumatology

Volumn 2014, Issue , 2014, Pages

  Hosseini, Naeimehossadat ^a   Bonakdar, Zahra Sayed ^a   Gholamrezaei, Ali ^b   Mirbagher, Leila ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Poursina Hakim Research Institute   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY IMAGE; CONCURRENT VALIDITY; CONTROLLED STUDY; CONVERGENT VALIDITY; DISCRIMINANT VALIDITY; DISEASE ACTIVITY; EMOTIONALITY; FATIGUE; HUMAN; INSTRUMENT VALIDATION; INTERNAL CONSISTENCY; INTIMACY; IRANIAN PEOPLE; LINGUISTICS; LUPUSQOL; MAJOR CLINICAL STUDY; PAIN; PLANNING; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84934906988     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2014/151530     Document Type: Article

References (21)

1. K. Baker and J. Pope, "Employment and work disability in systemic lupus erythematosus: a systematic review," Rheumatology, vol. 48, no. 3, pp. 281-284, 2009.
2. D. Isenberg and R. Ramsey-Goldman, "Assessing patients with lupus: towards a drug responder index," Rheumatology, vol. 38, no. 11, pp. 1045-1049, 1999.
3. V. Strand, D. Gladman, D. Isenberg, M. Petri, J. Smolen, and P. Tugwell, "Endpoints: consensus recommendations from OMERACT IV," Lupus, vol. 9, no. 5, pp. 322-327, 2000.
4. P. Fayers and D. Machin, Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes, John Wiley & Sons, New Jersey, NJ, USA, 2007.
5. K. P. Leong, K. O. Kong, B. Y. H. Tong et al., "Development and preliminary validation of a systemic lupus erythematosus-specifc quality-of-life instrument (SLEQOL)," Rheumatology, vol. 44, no. 10, pp. 1267-1276, 2005.
6. C. Grootscholten, G. Ligtenberg, R. H. Derksen et al., "Health-related quality of life in patients with systemic lupus ery-thematosus: development and validation of a lupus specifc symptom checklist," Quality of Life Research, vol. 12, no. 6, pp. 635-644, 2003.
7. L. C. Doward, S. P. McKenna, D. Whalley et al., "The development of the L-QoL: a quality-of-life instrument specifc to systemic lupus erythematosus," Annals of the Rheumatic Diseases, vol. 68, no. 2, pp. 196-200, 2009.
8. K. McElhone, J. Abbott, J. Shelmerdine et al., "Development and validation of a disease-specifc health-related quality of life measure, the LupusQoL, for adults with systemic lupus erythematosus," Arthritis Care and Research, vol. 57, no. 6, pp. 972-979, 2007.
9. J. Yazdany, "Health-related quality of life measurement in adult systemic lupus erythematosus: lupus quality of life (LupusQoL), Systemic Lupus Erythematosus-Specifc Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL)," Arthritis Care & Research, vol. 63, supplement 11, pp. S413-S419, 2011.
10. M. Castelino, J. Abbott, K. McElhone, and L.-S. Teh, "Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: a review of the literature," Rheumatology, vol. 52, no. 4, pp. 684-696, 2013.
11. F. Conti, C. Perricone, G. Reboldi et al., "Validation of a disease-specifc health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT," Lupus, vol. 23, no. 8, pp. 743-751, 2014.
12. S. L. Wang, B. Wu, L. Leng, R. Bucala, and L. J. Lu, "Validity of LupusQoL-China for the assessment of health related quality of life in Chinese patients with systemic lupus erythematosus," PLoS ONE, vol. 8, no. 5, Article ID e63795, 2013.
13. M. García-Carrasco, C. Mendoza-Pinto, M. H. Cardiel et al., "Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL," Lupus, vol. 21, no. 11, pp. 1219-1224, 2012.
14. H. Devilliers, Z. Amoura, J.-F. Besancenot et al., "Lupusqol-FR is valid to assess quality of life in patients with systemic lupus erythematosus," Rheumatology, vol. 51, no. 10, pp. 1906-1915, 2012.
15. N. Hosseini, S. Z. Bonakdar, A. Gholamrezaei, A. Fatemi, and H. Karimzadeh, "Evaluating the validity and reliability of Persian version of Lupus Quality of Life (LupusQol) questionnaire in Iranian patients," Journal of Isfahan Medical School, vol. 31, no. 260, pp. 1836-1847, 2014.
16. M. C. Hochberg, "Updating the American College of Rheumatology revised criteria for the classifcation of systemic lupus erythematosus," Arthritis and rheumatism, vol. 40, no. 9, p. 1725, 1997
17. D. Wild, A. Grove, M. Martin et al., "Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPORtask force for translation and cultural adaptation," Value in Health, vol. 8, no. 2, pp. 94-104, 2005.
18. D. D. Gladman, D. Ibanez, and M. B. Urowltz, "Systemic lupus erythematosus disease activity index 2000," Journal of Rheumatology, vol. 29, no. 2, pp. 288-291, 2002.
19. D. Gladman, M. Urowitz, P. Fortn et al., "Systemic Lupus International Collaborating Clinics conference on assessment of lupus fare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group," Journal of Rheumatology, vol. 23, no. 11, pp. 1953-1955, 1996.
20. A. Montazeri, A. Goshtasebi, M. Vahdaninia, and B. Gandek, "The Short Form Health Survey (SF-36): translation and validation study of the Iranian version," Quality of Life Research, vol. 14, no. 3, pp. 875-882, 2005.
21. M. Jolly, A. S. Pickard, C. Wilke et al., "Lupus-specifc health outcome measure for US patients: the LupusQoL-US version," Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 29-33, 2010.